Paul W. Hoelscher
CIK 1611468 · EVP, CFO · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
42
Lifetime Open-Market Net
-$62.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGMT | Director | — | $7.27 | — | $0 | 4 | 2026-06-15 |
| OnKure Therapeutics, Inc. (RPHM) Delisted | Director | — | $18.20 | — | $0 | 3 | 2023-06-08 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP, CFO | 89,264 | $116.30 | $10.38M | -$62.93M | 35 | 2022-04-22 |
Recent Filings · Page 2 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-24 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +63,531 | -$5.16M | EDGAR |
| 2021-12-30 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | −1,049 | -$806.4K | EDGAR |
| 2021-07-30 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +4,850 | -$395.4K | EDGAR |
| 2021-05-14 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Sell (S) | −102,925 | -$9.26M | EDGAR |
| 2021-02-19 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +1,313 | -$91.1K | EDGAR |
| 2021-01-22 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +3,094 | -$190.6K | EDGAR |
| 2021-01-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +169,132 | -$9.87M | EDGAR |
| 2020-08-25 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Sell (S) | −29,576 | -$2.24M | EDGAR |
| 2020-05-07 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Sell (S) | −104,994 | -$3.99M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.